Oncotelic Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1992
Revenue	0.07	0	0	1.74	0	-0	-0	0	0	0.1	Upgrade
Cost of Revenue	0	0.01	0.06	0	0.06	0	0	0	0	0	Upgrade
Gross Profit	0.07	-0.01	-0.06	1.74	-0.06	-0	-0	0	0	0.1	Upgrade
Selling, General & Admin	0.57	4.85	5.47	5.02	2.94	2.19	3.37	5	4.6	5.24	Upgrade
Research & Development	0.06	0.76	3.66	4.3	1.37	0.82	10.47	8.76	9.09	7.41	Upgrade
Other Operating Expenses	0.07	0.53	0	0	0	-0	-0.01	0	0	0	Upgrade
Operating Expenses	0.63	5.61	9.13	9.33	4.31	3	13.84	13.76	13.68	12.65	Upgrade
Operating Income	-0.56	-9.72	-9.13	-7.58	-4.31	-3	-13.84	-13.76	-13.68	-12.65	Upgrade
Interest Income	0	0	0	0	0	0.02	0.04	0.11	0	0	Upgrade
Interest Expense	1.04	2.97	2	2	0.75	0	0	0	0	0	Upgrade
Other Expense / Income	6.6	-17.37	-0.61	0.39	1.58	0.02	0.04	0.11	-	-	Upgrade
Pretax Income	-8.21	4.68	-10.52	-9.97	-6.64	-2.74	-13.81	-13.65	-13.65	-12.65	Upgrade
Income Tax	-0.3	-13.14	0.88	1.53	0.75	-0.27	-0.03	-0.11	-0.03	-0	Upgrade
Net Income	-7.9	17.82	-11.39	-11.5	-7.39	-2.74	-13.81	-13.65	-13.65	-12.65	Upgrade
Shares Outstanding (Basic)	396	384	303	88	60	37	27	27	25	17	Upgrade
Shares Outstanding (Diluted)	396	457	303	88	60	37	27	27	25	17	Upgrade
Shares Change	-13.37%	50.88%	244.02%	46.93%	60.96%	40.33%	-	5.33%	48.48%	505.53%	Upgrade
EPS (Basic)	-0.02	0.05	-0.04	-0.13	-0.12	-0.07	-0.52	-0.51	-0.54	-0.75	Upgrade
EPS (Diluted)	-0.02	0.04	-0.04	-0.13	-0.12	-0.07	-0.52	-0.51	-0.54	-0.75	Upgrade
Free Cash Flow	-1.32	-1.45	-4.43	-2.81	-2.28	-2.84	-10.93	-15.24	-11.94	-12.17	Upgrade
Free Cash Flow Per Share	-0.00	-0.00	-0.01	-0.03	-0.04	-0.08	-0.41	-0.57	-0.47	-0.72	Upgrade
Gross Margin	100.00%	-	-	100.00%	-	-	-	-	-	100.00%	Upgrade
Operating Margin	-806.96%	-	-	-435.69%	-	-	-	-	-	-13315.79%	Upgrade
Profit Margin	-11290.13%	-	-	-660.65%	-	-	-	-	-	-13312.63%	Upgrade
Free Cash Flow Margin	-1887.21%	-	-	-161.53%	-	-	-	-	-	-12808.42%	Upgrade
Effective Tax Rate	-	-281.04%	-	-	-	-	-	-	-	-	Upgrade
EBITDA	-0.56	-5.06	-9.06	-7.22	-4.25	-3.25	-13.83	-13.74	-13.69	-12.65	Upgrade
EBITDA Margin	-806.96%	-	-	-414.77%	-	-	-	-	-	-13318.95%	Upgrade
Depreciation & Amortization	0	0.01	0.06	0.36	0.06	0	0.01	0.02	0.02	0.11	Upgrade
EBIT	-	-5.08	-9.13	-7.58	-4.31	-3.25	-13.84	-13.76	-13.71	-12.76	Upgrade
EBIT Margin	-	-	-	-435.69%	-	-	-	-	-	-13433.68%	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.